| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 18 | 2010 | 34 | 0.760 |
Why?
|
| Interleukin-17 | 5 | 2011 | 109 | 0.710 |
Why?
|
| T-Lymphocytes | 12 | 2011 | 1275 | 0.590 |
Why?
|
| CD28 Antigens | 4 | 2011 | 94 | 0.580 |
Why?
|
| Thymus Gland | 11 | 2002 | 196 | 0.530 |
Why?
|
| Lymphocyte Activation | 11 | 2011 | 797 | 0.500 |
Why?
|
| Receptors, Immunologic | 3 | 2011 | 140 | 0.410 |
Why?
|
| Signal Transduction | 15 | 2011 | 3502 | 0.400 |
Why?
|
| Tenodesis | 1 | 2013 | 6 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 14 | 1999 | 302 | 0.400 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2011 | 10 | 0.360 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2009 | 2 | 0.300 |
Why?
|
| Antigens, CD | 5 | 2009 | 476 | 0.300 |
Why?
|
| CD4 Antigens | 6 | 2001 | 80 | 0.300 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 75 | 0.300 |
Why?
|
| Ubiquitin | 1 | 2009 | 95 | 0.290 |
Why?
|
| CD8 Antigens | 6 | 2001 | 82 | 0.290 |
Why?
|
| Ligands | 2 | 2009 | 476 | 0.280 |
Why?
|
| Killer Cells, Natural | 2 | 2009 | 286 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2004 | 666 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2004 | 424 | 0.260 |
Why?
|
| Mice | 32 | 2011 | 12269 | 0.260 |
Why?
|
| Shoulder Joint | 4 | 2013 | 98 | 0.250 |
Why?
|
| Interleukins | 4 | 2011 | 133 | 0.230 |
Why?
|
| Milk Proteins | 3 | 2002 | 24 | 0.230 |
Why?
|
| Interleukin-7 | 3 | 2002 | 47 | 0.230 |
Why?
|
| Mice, Transgenic | 16 | 2011 | 1587 | 0.220 |
Why?
|
| Molecular Sequence Data | 14 | 2011 | 2910 | 0.210 |
Why?
|
| Animals | 36 | 2011 | 28155 | 0.200 |
Why?
|
| Patient Positioning | 2 | 2014 | 65 | 0.190 |
Why?
|
| Cytokines | 4 | 2010 | 863 | 0.190 |
Why?
|
| Cell Differentiation | 8 | 2011 | 1621 | 0.180 |
Why?
|
| Arthroscopy | 3 | 2013 | 106 | 0.170 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 41 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 1101 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 12 | 2011 | 3435 | 0.150 |
Why?
|
| B-Lymphocyte Subsets | 2 | 1999 | 36 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2004 | 287 | 0.150 |
Why?
|
| Biomechanical Phenomena | 2 | 2013 | 489 | 0.150 |
Why?
|
| Amino Acid Sequence | 12 | 2011 | 2012 | 0.150 |
Why?
|
| Rotator Cuff | 2 | 2010 | 51 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 153 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2011 | 2850 | 0.140 |
Why?
|
| Calcium | 3 | 2004 | 1176 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 1985 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2011 | 2121 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 474 | 0.120 |
Why?
|
| Cadaver | 2 | 2013 | 199 | 0.110 |
Why?
|
| Anesthesia, General | 2 | 2014 | 128 | 0.110 |
Why?
|
| Cell Line | 7 | 2011 | 2464 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 238 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2002 | 439 | 0.100 |
Why?
|
| GATA3 Transcription Factor | 2 | 2010 | 52 | 0.100 |
Why?
|
| Anesthesia, Conduction | 1 | 2013 | 24 | 0.100 |
Why?
|
| Hematopoiesis | 2 | 1993 | 183 | 0.090 |
Why?
|
| Awards and Prizes | 1 | 2013 | 37 | 0.090 |
Why?
|
| Rotator Cuff Injuries | 2 | 2010 | 52 | 0.090 |
Why?
|
| Oximetry | 1 | 2013 | 90 | 0.090 |
Why?
|
| T-Box Domain Proteins | 2 | 2010 | 127 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2013 | 273 | 0.090 |
Why?
|
| Receptors, Interleukin-7 | 3 | 2002 | 30 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 24 | 0.090 |
Why?
|
| Lymphocytes | 4 | 2003 | 454 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 71 | 0.090 |
Why?
|
| Humans | 21 | 2014 | 93515 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2011 | 120 | 0.080 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 423 | 0.080 |
Why?
|
| Suture Anchors | 1 | 2010 | 7 | 0.080 |
Why?
|
| Cricetinae | 2 | 2011 | 532 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2009 | 278 | 0.080 |
Why?
|
| Tendons | 1 | 2010 | 48 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 1234 | 0.080 |
Why?
|
| Enzyme Activation | 6 | 2004 | 674 | 0.080 |
Why?
|
| Protein Transport | 2 | 2009 | 438 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2010 | 163 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 167 | 0.080 |
Why?
|
| B7 Antigens | 1 | 2009 | 5 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 109 | 0.080 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1993 | 16 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2014 | 41 | 0.080 |
Why?
|
| Antibodies, Bispecific | 1 | 2009 | 38 | 0.080 |
Why?
|
| K562 Cells | 1 | 2009 | 48 | 0.070 |
Why?
|
| Interleukin-23 | 1 | 2009 | 60 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2010 | 184 | 0.070 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2009 | 26 | 0.070 |
Why?
|
| Bursa, Synovial | 1 | 2009 | 3 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2009 | 97 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2010 | 149 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2009 | 408 | 0.070 |
Why?
|
| Tendon Injuries | 1 | 2009 | 39 | 0.070 |
Why?
|
| Transfection | 4 | 2007 | 880 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 255 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 203 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2009 | 150 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 114 | 0.070 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 181 | 0.070 |
Why?
|
| Protein Binding | 4 | 2007 | 1534 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 337 | 0.070 |
Why?
|
| Interleukin-2 | 3 | 2011 | 244 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 141 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 555 | 0.070 |
Why?
|
| Receptors, Cytokine | 4 | 2011 | 30 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 603 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 1996 | 96 | 0.060 |
Why?
|
| Male | 12 | 2014 | 44557 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 159 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 824 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2011 | 536 | 0.060 |
Why?
|
| Tyrosine | 5 | 2002 | 131 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 219 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 481 | 0.060 |
Why?
|
| Species Specificity | 1 | 2007 | 684 | 0.060 |
Why?
|
| Flow Cytometry | 6 | 2010 | 712 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2009 | 463 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 3 | 2002 | 44 | 0.060 |
Why?
|
| Apoptosis | 2 | 2004 | 1721 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 4072 | 0.050 |
Why?
|
| src-Family Kinases | 3 | 2004 | 70 | 0.050 |
Why?
|
| Transgenes | 2 | 2004 | 171 | 0.050 |
Why?
|
| Dermatitis | 1 | 2004 | 34 | 0.050 |
Why?
|
| Middle Aged | 6 | 2014 | 27573 | 0.050 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 17 | 0.050 |
Why?
|
| Stroke | 1 | 2013 | 1079 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 80 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2755 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 160 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1768 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1993 | 68 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 493 | 0.050 |
Why?
|
| Aged | 4 | 2014 | 20434 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 216 | 0.050 |
Why?
|
| Stromal Cells | 2 | 2002 | 151 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 272 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 261 | 0.040 |
Why?
|
| Female | 9 | 2014 | 48702 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 701 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 40 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 2004 | 22 | 0.040 |
Why?
|
| Phosphorylation | 3 | 1999 | 1133 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2010 | 134 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 45 | 0.040 |
Why?
|
| Proline | 1 | 1999 | 49 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 894 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 1395 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1999 | 39 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2010 | 248 | 0.040 |
Why?
|
| Base Sequence | 5 | 1994 | 2220 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 59 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 161 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2010 | 460 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 60 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 94 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1991 | 457 | 0.030 |
Why?
|
| Fetus | 1 | 1999 | 236 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 1999 | 264 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2003 | 515 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1996 | 33 | 0.030 |
Why?
|
| CD3 Complex | 3 | 2004 | 135 | 0.030 |
Why?
|
| Gene Expression | 3 | 1994 | 1301 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 33 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 94 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 59 | 0.030 |
Why?
|
| Shoulder | 1 | 2014 | 42 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 1210 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1492 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 67 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1993 | 9 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 113 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1993 | 111 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 125 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2004 | 2026 | 0.020 |
Why?
|
| Mitosis | 1 | 1993 | 150 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1993 | 111 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1922 | 0.020 |
Why?
|
| Citrobacter rodentium | 1 | 2011 | 14 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 12 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2011 | 49 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 505 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 22 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2004 | 730 | 0.020 |
Why?
|
| fas Receptor | 2 | 2004 | 73 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1028 | 0.020 |
Why?
|
| Thymoma | 1 | 1991 | 32 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2010 | 4 | 0.020 |
Why?
|
| Oncogenes | 1 | 1991 | 100 | 0.020 |
Why?
|
| L-Selectin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 122 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1991 | 46 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 713 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2000 | 587 | 0.020 |
Why?
|
| Shoulder Dislocation | 1 | 2010 | 17 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 66 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2013 | 4560 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 200 | 0.020 |
Why?
|
| Alleles | 1 | 1993 | 1139 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 281 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 896 | 0.020 |
Why?
|
| Catheters | 1 | 2010 | 96 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 108 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2010 | 169 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 5410 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2010 | 87 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 93 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2009 | 21 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2010 | 88 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 38 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 331 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 367 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 52 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 103 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 174 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 696 | 0.020 |
Why?
|
| Sprains and Strains | 1 | 2009 | 12 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 524 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 948 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 235 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 675 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 122 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 86 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1701 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 540 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 355 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2010 | 406 | 0.020 |
Why?
|
| Proteins | 1 | 1993 | 803 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2009 | 563 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1987 | 122 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1799 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 693 | 0.010 |
Why?
|
| Peptides | 2 | 1999 | 656 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3830 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 990 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1991 | 1338 | 0.010 |
Why?
|
| Mutation | 3 | 1998 | 4272 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 1050 | 0.010 |
Why?
|
| Lectins, C-Type | 2 | 1996 | 89 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1741 | 0.010 |
Why?
|
| Spleen | 2 | 1998 | 374 | 0.010 |
Why?
|
| Receptors, Oncostatin M | 1 | 2004 | 1 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 25 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 38 | 0.010 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2004 | 36 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 47 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 2003 | 21 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2003 | 1264 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 66 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 102 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 85 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1265 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 187 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 86 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 352 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2562 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 138 | 0.010 |
Why?
|
| Antigens | 1 | 2004 | 224 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 2002 | 10 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Protein Kinase C-theta | 1 | 2002 | 16 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 2391 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 162 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 315 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 282 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 223 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 962 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 409 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 555 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 470 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2465 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2002 | 145 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 444 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 274 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 691 | 0.010 |
Why?
|
| Phosphotyrosine | 2 | 1991 | 31 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 224 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 454 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 729 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1999 | 1 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7622 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 1999 | 20 | 0.010 |
Why?
|
| Genes, fos | 1 | 1999 | 24 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1999 | 84 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 83 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 664 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 73 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 1713 | 0.010 |
Why?
|
| Ionomycin | 1 | 1998 | 19 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1998 | 108 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 85 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1518 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 98 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 1998 | 163 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 298 | 0.010 |
Why?
|
| Lung | 1 | 2004 | 1366 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 27918 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1996 | 18 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 211 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1994 | 63 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1993 | 16 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 258 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1993 | 46 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1994 | 613 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1992 | 224 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 36 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 292 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 164 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 1052 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1991 | 422 | 0.000 |
Why?
|
| Moloney murine leukemia virus | 1 | 1989 | 5 | 0.000 |
Why?
|
| Cysteine | 1 | 1990 | 145 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 210 | 0.000 |
Why?
|
| Binding Sites | 1 | 1991 | 1133 | 0.000 |
Why?
|
| Lysine | 1 | 1989 | 182 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1989 | 756 | 0.000 |
Why?
|
| Melanoma | 1 | 1987 | 495 | 0.000 |
Why?
|
| Phenotype | 1 | 1989 | 2544 | 0.000 |
Why?
|